LEO Pharma Appoints Marika Murto to Lead Global Product Strategy

• Marika Murto brings over 20 years of pharmaceutical expertise in product strategy, innovation, and business transformation
• Her appointment as SVP of Global Product Strategy will help unlock LEO Pharma’s portfolio potential, driving patient impact and supporting sustainable growth

BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma, a global leader in medical dermatology, announces the appointment of Marika Murto, PhD, as SVP of Global Product Strategy and member of the Global Leadership Team.

Marika joins LEO Pharma from Amgen, where she most recently served as Associate Vice President and U.S. Commercial Lead for Bone Health, driving strategic brand positioning and cross‑functional collaboration. Her career at Amgen included senior global and affiliate leadership roles, including General Manager for the Netherlands, Global Product Team Lead for Bone Health, and Country Director for Finland. She has also held senior commercial positions at Pfizer and Roche, gaining expertise across oncology, vaccines, specialty medicines, and portfolio strategy.

“I’m very excited to join LEO Pharma and lead Global Product Strategy at such an important point in the company’s journey. Effective product strategy is about uniting great science, market insight, and organizational excellence to create meaningful results for patients. I’m passionate about empowering diverse, results driven teams and embedding innovation in all that we do,” says Marika Murto.

With her deep global experience and ability to combine scientific understanding with strategic execution, Marika will play a key role in shaping the direction of LEO Pharma’s portfolio, ensuring it is positioned to deliver strong impact for patients and sustainable growth for the company.

“Marika’s strong international background, strategic mindset, and ability to connect vision with delivery make her an outstanding choice to lead Global Product Strategy. She has shown throughout her career that she can shape complex portfolios and succeed across diverse markets. I very much look forward to welcoming her to the LEO Pharma team,” says Christophe Bourdon, CEO.

“I’d like to sincerely thank Lisa Elliot for stepping in as interim head of Global Product Strategy during this important period. I’m truly pleased that she will continue to contribute her expertise, dedication, and deep knowledge of our company in her previous role within Global Asset & Payer Strategy,” says Christophe.

Marika Murto will join LEO Pharma as Senior Vice President of Global Product Strategy on February 1, 2026.